. Adjusted association between a 1 ug/m 3 higher PM 2.5 exposure over varying lags and SD-unit brain volumes in 2011-2013 in participants from the ARIC-NCS study for sensitivity analyses (e1) incorporating IPAW weights for non-death drop out. Table S2 . Adjusted association between a 1 ug/m 3 higher PM 2.5 exposure over varying lags and SD-unit brain volumes in 2011-2013 in participants from the ARIC-NCS study for sensitivity analyses (e2) incorporating IPAW weights for death and non-death drop-out. Table S3 . Adjusted association between a 1 ug/m 3 higher PM 2.5 exposure over varying lags and SD-unit brain volumes in 2011-2013 in participants from the ARIC-NCS study for sensitivity analyses (h) omitting weighting. Table S4 . Adjusted association between a 1 ug/m 3 higher PM 10 exposure over varying lags and SD-unit brain volumes in 2011-2013 in participants from the ARIC-NCS study for sensitivity analysis (e1) incorporating IPAW for non-death drop-out. Table S5 . Adjusted association between a 1 ug/m 3 higher PM 10 exposure over varying lags and SD-unit brain volumes in 2011-2013 in participants from the ARIC-NCS study for sensitivity analysis (e2) incorporating IPAW for death and non-death drop-out. Table S6 . Adjusted association between a 1 ug/m 3 higher PM 10 exposure over varying lags and SD-unit brain volumes in 2011-2013 in participants from the ARIC-NCS study for sensitivity analysis (h) omitting weights. Table S7 . Adjusted association between a 1 ug/m 3 higher PM 2.5 exposure over varying lags and SD-unit presence of MRI markers of cerebrovascular disease in 2011-2013 in participants from the ARIC-NCS study. Table S8 . Adjusted association between a 1 ug/m 3 higher PM 10 exposure over varying lags and presence of MRI markers of cerebrovascular disease in 2011-2013 in participants from the ARIC-NCS study. Table S9 . Adjusted association between a 1 ug/m 3 higher PM 2.5 exposure over varying lags and presence of MRI markers of cerebrovascular disease in 2011-2013 in participants from the ARIC-NCS study for sensitivity analysis (e1) incorporating IPAW for non-death drop-out. Table S10 . Adjusted association between a 1 ug/m 3 higher PM 2.5 exposure over varying lags and presence of MRI markers of cerebrovascular disease in 2011-2013 in participants from the ARIC-NCS study for sensitivity analysis (e2) incorporating IPAW for death and non-death drop-out. Table S11 . Adjusted association between a 1 ug/m 3 higher PM 2.5 exposure over varying lags and presence of MRI markers of cerebrovascular disease in 2011-2013 in participants from the ARIC-NCS study for sensitivity analysis (h) omitting weights. Table S12 . Adjusted association between a 1 ug/m 3 higher PM 10 exposure over varying lags and presence of MRI markers of cerebrovascular disease in 2011-2013 in participants from the ARIC-NCS study for sensitivity analysis (e1) incorporating IPAW for non-death drop-out. Table S13 . Adjusted association between a 1 ug/m 3 higher PM 10 exposure over varying lags and presence of MRI markers of cerebrovascular disease in 2011-2013 in participants from the ARIC-NCS study for sensitivity analysis (e2) incorporating IPAW for death and non-death drop-out. Table S14 . Adjusted association between a 1 ug/m 3 higher PM 10 exposure over varying lags and presence of MRI markers of cerebrovascular disease in 2011-2013 in participants from the ARIC-NCS study for sensitivity analysis (h) omitting weights. 
